Cardiac biomarkers combined with neuroimaging localization predict long-term outcomes in acute stroke patients
Open Access
- 8 June 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Cardiac biomarker elevation is common after stroke, but its relationship with stroke localization and long-term outcomes remains incompletely characterized. This prospective observational cohort study enrolled 695 patients (380 ischemic stroke, 135 TIA, 180 hemorrhagic stroke) from October 2020 to July 2023. High-sensitivity cardiac troponin I (hs-cTnI), NT-proBNP, and CK-MB were measured at admission and at 12–24 h. Ischemic strokes were categorized by localization (insular involvement, anterior non-insular, posterior circulation, subcortical-only). Primary outcomes were 1-year all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE). Biomarker elevations varied significantly by stroke type and localization. Hemorrhagic stroke showed the highest hs-cTnI (median 28.7 ng/L) and troponin elevation rate (54.4%). Among ischemic strokes, insular involvement demonstrated the highest biomarker levels (hs-cTnI 45.8 ng/L, NT-proBNP 892 pg/mL, troponin elevation 73.9%; all p < 0.001 versus other localizations). At 1 year, overall mortality was 20.4% and MACCE 31.4%. Elevated troponin independently predicted mortality (HR 3.24, 95% CI 2.18–4.82), MACCE (HR 2.86), and recurrent stroke (HR 1.92). A synergistic interaction between troponin elevation and insular involvement was identified for mortality (interaction HR 2.15, p = 0.029) and MACCE (interaction HR 1.84, p = 0.016). Hs-cTnI demonstrated good discriminative ability (AUC 0.782 for mortality, 0.745 for MACCE). Cardiac biomarker elevation, particularly in insular strokes, independently predicts adverse outcomes. Routine biomarker assessment combined with stroke localization data may enhance risk stratification and guide targeted interventions.Keywords
This publication has 32 references indexed in Scilit:
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Neurology, 2021
- Post-Stroke Cardiovascular Complications and Neurogenic Cardiac InjuryJACC, 2020
- Stroke–heart syndrome: clinical presentation and underlying mechanismsThe Lancet Neurology, 2018
- Prognostic relevance of cardiac troponin T levels and their dynamic changes measured with a high-sensitivity assay in acute ischaemic stroke: Analyses from the TRELAS cohortInternational Journal of Cardiology, 2014
- Electrocardiographic abnormalities and cardiac arrhythmias in structural brain lesionsInternational Journal of Cardiology, 2013
- Brain Natriuretic Peptide Levels as a Predictor for New Atrial Fibrillation During Hospitalization in Patients With Acute Ischemic StrokeThe American Journal of Cardiology, 2012
- Cardiovascular and neurological causes of sudden death after ischaemic strokeThe Lancet Neurology, 2012
- Relation of Cardiac Troponin I Levels With In-Hospital Mortality in Patients With Ischemic Stroke, Intracerebral Hemorrhage, and Subarachnoid HemorrhageThe American Journal of Cardiology, 2008
- Abnormalities on ECG and telemetry predict stroke outcome at 3 monthsJournal of the Neurological Sciences, 2005
- Cerebrogenic Cardiac ArrhythmiasArchives of Neurology, 1990